Tag - medicine

 
 

MEDICINE

Japan Times
WORLD / Science & Health
Mar 9, 2023
COVID lab leak fight obscures the global rise of high-security biolabs
Scientific safety has re-emerged as a high-stakes global issue after the U.S. suggested it had intelligence showing a lab leak was the most likely origin of the COVID-19 pandemic.
Japan Times
COMMENTARY / World
Mar 8, 2023
Obesity drugs for kids? Why new guidelines make sense
The American Academy of Pediatrics thinks drugs like Wegovy and Mounjaro could help teens with weight loss.
Japan Times
BUSINESS
Mar 4, 2023
Japanese pharmaceutical firm Takeda lowers price of dengue shot in Brazil and Indonesia
The cost for Qdenga in Indonesia will be about one-third its European price, far lower than many other innovative vaccines, Takeda CEO Christophe Weber said in an interview.
Japan Times
WORLD / Science & Health
Mar 3, 2023
Scientists explore ocean frontiers seeking drugs from the deep
The huge biological diversity of the oceans means there are likely many more marine genetic resources to be discovered and used in medicines and antibiotics.
Japan Times
WORLD / Science & Health
Mar 2, 2023
Viruses hiding out in patients hold long COVID answers
Scientists are exploring the possibility that some of the most infectious versions of the virus came from chronically infected individuals with weakened immune systems.
Japan Times
COMMENTARY / World
Mar 1, 2023
A sick America can’t compete with global powers
Poor health is not just a tragedy for individuals. It is a constraint on the U.S.’s productivity and its ability to defend itself.
Japan Times
JAPAN / Science & Health
Mar 1, 2023
Early detection of postpartum depression? Japanese researchers may have found a way.
Currently, there are no available tests that aid with the prediction of postpartum depression.
Japan Times
JAPAN / Science & Health
Feb 28, 2023
Japan health ministry panel endorses nasal flu vaccine for children
Based on the results of a clinical trial involving children in Japan, the panel agreed that FluMist Quadrivalent is safe and effective in preventing the flu.
Japan Times
BUSINESS / Companies
Feb 27, 2023
Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval
CEO Isao Teshirogi said he expects U.S. approval of the drug could come by the winter of 2024, pending a late-stage trial.
Japan Times
COMMENTARY / World
Feb 27, 2023
A refreshing gamble on Crispr delivery
Biotech startup Aera is trying to shake up the always-just-out-of-reach field of genetic medicine.
Japan Times
JAPAN / Explainer
Feb 27, 2023
Japan moves toward approving abortion pill in major shift
Currently, surgery is the only option available to terminate a pregnancy in Japan.
JAPAN / Science & Health
Feb 22, 2023
Shionogi says its drug Xocova may reduce risks of long COVID symptoms
For 14 major symptoms of COVID-19, 14.5% of those given Xocova reported at least one of the symptoms six months after the start of treatment, compared with 26.3% who were given a placebo.
Japan Times
WORLD
Feb 22, 2023
Hong Kong revokes visa of scientist jailed for creating first gene-edited babies
He Jiankui was imprisoned in 2019 for experimenting on human embryos, in a controversial exercise that saw twin girls born with genes he altered while trying to confer immunity to HIV.
Japan Times
WORLD
Feb 9, 2023
Trial of new COVID-19 treatment yields encouraging results, study shows
Stanford University professor Jeffrey Glenn, co-author of the study, said the new drug 'showed profound benefits for vaccinated and unvaccinated people alike.'
BUSINESS / Tech
Feb 8, 2023
Competition intensifies in Japan's surgical robot market
If prices fall as a result of growing competition, this may help spread the use of such robots and make them more accessible to more patients.
JAPAN / Politics
Feb 7, 2023
Japan's government adopts bills to prepare for future pandemics
The government will also establish an infectious disease crisis management agency at the Cabinet Secretariat possibly in fall this year.
Japan Times
COMMENTARY / World
Jan 30, 2023
One-size-fits-all COVID-19 booster plan needs a rethink
Public health officials should recognize that additional COVID-19 booster shots should now be a more nuanced decision.
Japan Times
JAPAN
Jan 30, 2023
Priority review status given to Alzheimer's drug developed by Eisai and Biogen
The companies said priority review in Japan is granted to new medicines recognized as having high medical utility for serious diseases.

Longform

Professional cleaner Hirofumi Sakurai takes a moment to appreciate some photographs in a Gotanda apartment whose occupant died alone.
The last cleanup: Life and death in a lonely Japan